West Pharmaceutical Services Inc.

WST | NYSE

Price Alert Chart Builder DCF Calculator

$363.15

+$0.84 (+0.23%)

Sep 21, 2026, 1:40 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	3.33B	3.22B	3.07B	3.02B	2.96B	2.9B	2.89B	2.88B	2.88B	2.93B	2.95B	2.93B	2.86B	2.88B	2.89B	2.91B	2.93B	2.88B	2.83B	2.68B	2.52B	2.33B
Cost of Revenue	2.1B	2.05B	1.97B	1.94B	1.91B	1.89B	1.89B	1.87B	1.85B	1.84B	1.82B	1.81B	1.77B	1.76B	1.75B	1.74B	1.74B	1.7B	1.66B	1.59B	1.53B	1.46B
Gross Profit	1.22B	1.17B	1.1B	1.07B	1.05B	1B	1B	1.01B	1.03B	1.09B	1.13B	1.12B	1.09B	1.12B	1.14B	1.16B	1.19B	1.18B	1.17B	1.09B	991.5M	869.6M
Operating Income	686.5M	665.6M	616.9M	630.9M	625M	597.6M	596.2M	596.2M	619.5M	676M	716.5M	707.7M	704.2M	740.8M	760.1M	779.2M	775.1M	761.1M	754.6M	696M	619.2M	517.5M
Interest Income	14.4M	16.8M	17.7M	17.2M	17.1M	17.5M	19.6M	24.2M	28.4M	29.4M	28M	21.5M	14.2M	9.6M	5.1M	2.5M	1.4M	1.2M	1M	900K	700K	700K
Pretax Income	699.6M	681.5M	615.3M	616.8M	611.2M	582.4M	600.2M	604.8M	627.1M	683.8M	715.7M	676.1M	626.4M	669.2M	700.6M	750.6M	797.2M	784.1M	769M	705.9M	621.7M	509.3M
Net Income	564.9M	542.7M	493.7M	491.7M	487.7M	467.2M	492.7M	499.6M	524.9M	568.7M	593.4M	559.4M	518.7M	552.1M	585.9M	630.6M	685.6M	684.4M	661.8M	612.5M	519.2M	423.1M
Selling & General & Admin	426.3M	404.6M	393.1M	371.9M	351.1M	338.2M	336.9M	341.6M	348.7M	354.1M	353.4M	349.1M	326.4M	319.5M	316.9M	329.2M	354.8M	366M	362.8M	341.1M	320.9M	303.7M
Research & Development	74.4M	73.8M	74.3M	71M	69.4M	67.8M	69.1M	69M	69.9M	68.9M	68.4M	65.9M	63.1M	61M	58.5M	56.3M	55.8M	55.2M	52.8M	52M	51.4M	48.4M
Other Expenses	35.3M	22.5M	18.5M	n/a	n/a	n/a	n/a	n/a	-7M	-7M	-7M	-7M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	536M	500.9M	485.9M	442.9M	420.5M	406M	406M	410.6M	411.6M	416M	414.8M	408M	389.5M	380.5M	375.4M	385.5M	410.6M	421.2M	415.6M	393.1M	372.3M	352.1M
Interest Expense	100K	200K	600K	600K	1.2M	2.6M	3.7M	4.8M	7M	8.1M	8.8M	9.3M	8.5M	7.7M	7.6M	9.1M	8.7M	8.7M	8.4M	8M	8.3M	8.4M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.64B	2.55B	2.46B	2.39B	2.33B	2.3B	2.3B	2.28B	2.26B	2.25B	2.23B	2.22B	2.16B	2.14B	2.13B	2.13B	2.15B	2.12B	2.08B	1.99B	1.9B	1.81B
Income Tax Expense	144.2M	142.2M	121.6M	125.1M	123.5M	115.2M	107.5M	105.2M	102.2M	115.1M	122.3M	116.7M	107.7M	117.1M	114.7M	120M	111.6M	99.7M	107.2M	93.4M	102.5M	86.2M
Shares Outstanding (Basic)	70.8M	72M	72.3M	72.3M	72.3M	72.5M	73M	72.8M	73M	73.5M	74.1M	74.3M	74.3M	74.5M	74.4M	74.4M	74.4M	74.4M	74.5M	74.1M	74M	73.9M
Shares Outstanding (Diluted)	71.3M	72.4M	72.7M	72.7M	72.8M	73M	73.7M	73.4M	73.7M	74.3M	75M	75.3M	75.4M	75.7M	75.6M	75.7M	75.8M	76M	76.4M	76M	75.7M	75.8M
EPS (Basic)	7.87	7.52	6.83	6.79	6.72	6.42	6.75	6.81	7.11	7.68	7.99	7.52	6.97	7.41	7.87	8.47	9.22	9.22	8.92	8.27	7.01	5.72
EPS (Diluted)	7.82	7.49	6.80	6.76	6.68	6.37	6.69	6.74	7.03	7.58	7.88	7.41	6.86	7.29	7.73	8.30	9.02	9	8.70	8.06	6.84	5.58
EBITDA	824.2M	843.6M	776M	772.1M	760.4M	731M	744.6M	744.2M	764.4M	816.9M	844.1M	800.3M	742.8M	780.3M	807.7M	865.7M	910.4M	892.9M	879.6M	806.5M	721.8M	610.3M
EBIT	689.6M	667.6M	604.6M	607M	598.1M	571.2M	589.2M	593.6M	618.3M	675.6M	706.8M	667.8M	616.2M	657.7M	687.1M	741.8M	786.3M	770.1M	757.3M	690.1M	602.8M	493.9M
Depreciation & Amortization	134.6M	176M	171.4M	165.1M	162.3M	159.8M	155.4M	150.6M	146.1M	141.3M	137.3M	132.5M	126.6M	122.6M	120.6M	123.9M	124.1M	122.8M	122.3M	116.4M	119M	116.4M